FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

12 letters match. Newest first.

  1. Dry Springs Pharmacy

    FDA warned Dry Springs Pharmacy that its website sells unapproved and misbranded opioids, benzodiazepines, and stimulants to U.S. consumers.

    High risk
  2. onlineotcmeds.com

    FDA warned onlineotcmeds.com for selling unapproved, misbranded opioids, benzodiazepines, and Schedule II stimulants to U.S. consumers online.

    High risk
  3. www.usmedschoice.com

    FDA warned www.usmedschoice.com for selling unapproved and misbranded opioids, benzodiazepines, and stimulants online without prescriptions.

    High risk
  4. motionpharmacy.com

    FDA warns motionpharmacy.com over selling unapproved and misbranded prescription drugs online.

    High risk
  5. www.mysteroidsmarket.com

    FDA warns Israel-based website mysteroidsmarket.com for selling unapproved and misbranded stimulants and benzodiazepines to U.S. consumers.

    High risk
  6. www.d-pharmacy.com

    FDA warned Singapore website d-pharmacy.com for selling unapproved prescription opioids, benzodiazepines, and stimulants to U.S. consumers.

    High risk
  7. www.portmeds.com

    FDA warned www.portmeds.com for selling unapproved, misbranded opioids, benzodiazepines, and Schedule II stimulants online without prescriptions.

    High risk
  8. www.plakini-pharma.com

    FDA warned Malaysia-based website plakini-pharma.com for selling unapproved, misbranded opioids, benzodiazepines, and stimulants to U.S. consumers.

    High risk
  9. www.soma4ever.com

    FDA warned soma4ever.com for selling unapproved and misbranded opioids, benzodiazepines, and stimulants to U.S. consumers online.

    High risk
  10. www.trinexpharmacy.com

    FDA warned trinexpharmacy.com for selling unapproved tramadol and misbranded Adderall without prescriptions to U.S. consumers.

    High risk
  11. kubapharm.com

    FDA and DEA warned kubapharm.com it unlawfully sells high-abuse-risk stimulants, including Adderall, online without required registrations or prescriptions.

    High risk
  12. premiumlightsupplier.com

    FDA and DEA warned premiumlightsupplier.com that it unlawfully sells Schedule II stimulants, including Adderall, online without prescriptions or DEA registration.

    High risk